Cell sorting market continues to surge with advancements in technology and methods. The latest innovations, including high-speed sorting and single-cell analysis, are driving growth. These technologies enable precise isolation and analysis of cells, crucial in research and clinical applications. Market expansion is fueled by increased demand in biotechnology and pharmaceutical sectors for personalized medicine and drug development. Emerging economies are adopting these technologies, contributing to market diversification. Overall, the cell sorting market is poised for significant expansion, driven by technological advancements catering to diverse research and clinical needs.
Data Bridge Market Research analyses that the Global Cell Sorting Market size was valued at USD 443.05 million in 2023, is expected to reach USD 669.70 million by 2031, and is expected to undergo a CAGR of 5.3% during the forecast period of 2024 to 2031.
To know more about the study, visit: https://www.databridgemarketresearch.com/ko/reports/global-cell-sorting-market
Below are the Top Five Cell Sorting Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
BD
|
BD is a global medical technology company known for its expertise in diagnostics, biosciences, and medical devices. In the cell sorting market, BD offers a range of flow cytometry solutions, including advanced cell sorters that enable researchers to isolate and analyze specific cell populations with high precision. Their products are widely used in academic research, clinical laboratories, and pharmaceutical industries, contributing to advancements in immunology, oncology, and infectious disease research.
|
|
Middle East and Africa, Europe, Asia-Pacific, North America, South America
|
In April 2018, BD announced that they have launched BD FACSymphony S6 cell sorter, this new product has ability to sort cell populations to better understand cell phenotypes for multi-omics research as well as immunology. This development has enhanced the company product portfolio and generated adequate revenue.
|
|
2.
|
Beckman Coulter, Inc.
|
Beckman Coulter is renowned for its advanced flow cytometry and cell sorting technologies. Their systems are known for high throughput, reliability, and accuracy in cell analysis and sorting applications. They cater to a wide range of research, clinical, and industrial needs, offering solutions that integrate seamlessly into laboratory workflows.
|
|
Middle East and Africa, Europe, Asia-Pacific, North America, South America
|
In June 2019, Beckman Coulter, Inc. (a subsidiary of Danaher) Life Sciences announced that they have acquired Cytobank which is a single cell data analysis, software as a service (SaaS) company. This development enhanced the credibility of the company.
|
|
3.
|
Bio-Rad Laboratories, Inc.
|
Bio-Rad is a key player in the cell sorting market, focusing on innovative technologies that enhance precision and efficiency in cell biology research. Their systems are designed to meet diverse experimental requirements, combining ease of use with robust performance for both academic and biopharmaceutical applications.
|
|
Middle East and Africa, Europe, Asia-Pacific, North America, South America
|
In April 2015, Bio-Rad Laboratories, Inc. announced that they have launched S3e Cell Sorter (488/640 nm) which is an easy-to-use product. This development has enhanced the company product portfolio and generated adequate revenue.
|
|
4.
|
Miltenyi Biotec
|
Miltenyi Biotec specializes in providing comprehensive solutions for cell biology research, including advanced cell sorting technologies. Their products are notable for their versatility, enabling researchers to isolate and analyze cells with high purity and viability. Miltenyi Biotec's systems are widely used in immunology, oncology, and stem cell research.
|
|
Middle East and Africa, Europe, Asia-Pacific, North America
|
In January 2020, Miltenyi Biotec announced that they have launched GMP-compliant cell sorting system which is a first operator-free GMP-compliant cell sorting system. This development enhances the company product portfolio and generates adequate revenue.
|
|
5.
|
Thermo Fisher Scientific Inc.
|
Thermo Fisher Scientific offers a broad spectrum of cell sorting solutions, leveraging their expertise in instrumentation and reagents. Their platforms are known for their scalability and integration capabilities, supporting applications from basic research to clinical diagnostics. Thermo Fisher's commitment to innovation ensures that their products remain at the forefront of advancing cellular analysis and sorting technologies.
|
|
Middle East and Africa, Europe, Asia-Pacific, North America, South America
|
In February 2029, Thermo Fisher Scientific Inc. announced that they have received multiple prestigious industry awards for their analytical instrument. These awards have been recognized for the best new products across the industry. This development has enhanced the credibility of the company.
|
Conclusion
The cell sorting market is poised for substantial growth driven by advancements in biotechnology and pharmaceutical research. Increasing demand for personalized medicine and diagnostics, coupled with expanding applications in cancer research and stem cell therapy, fuels this growth. Technological innovations such as high-speed cell sorters and advanced flow cytometry techniques further boost market prospects. As healthcare sectors worldwide emphasize precision medicine, the cell sorting market stands to benefit significantly from these trends, offering lucrative opportunities for market players to innovate and expand their portfolios in the coming years.
